VCP
ABMD

Verus Capital Partners’s Abiomed Inc ABMD Stock Holding History

Verus Capital Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$17K Buy
+114
New +$18.9K 0.01% 857

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Verus Capital Partners's ABMD Position: Q1 2020 in Review

Verus Capital Partners opened a new position in Abiomed Inc (ABMD) in Q1 2020: 114 shares worth $17K. The stake represents 0.01% of the portfolio and ranks #857 among its holdings.

412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • Verus Capital Partners held 114 shares of Abiomed Inc worth $17K as of Q1 2020.
  • Abiomed Inc was a new Verus Capital Partners position in Q1 2020.
  • Abiomed Inc made up 0.01% of Verus Capital Partners's portfolio in Q1 2020, its #857 holding.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.